Patent 7696363 was granted and assigned to YASOO HEALTH, INC. on April, 2010 by the United States Patent and Trademark Office.
Disclosed is an improved method for preparing the isoflavonoid compound (+/−)-equol, the method comprising reducing an organic diester of the isoflavone daidzein under hydrogen-transfer conditions using palladium hydroxide catalyst.